<DOC>
	<DOC>NCT00174278</DOC>
	<brief_summary>To assess the effect of long-term treatment by Genotonorm on linear growth</brief_summary>
	<brief_title>Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism, Pituitary</mesh_term>
	<mesh_term>Dwarfism</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>All the patients who have benefit during one year of a treatment by Genotonorm during the study 948123014 All patients who have stopped during one year will be included if a signed written informed consent Endocrine disease, except well substituted hypothyroidism Other severe chronic diseases (e.g. diabetes mellitus, cardiac or liver insufficiency)</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>